Asthma is a common disease with a complex risk architecture including both genetic and environmental factors. We performed a meta-analysis of North American genome-wide association studies of asthma in 5,416 individuals with asthma (cases) including individuals of European American, African American or African Caribbean, and Latino ancestry, with replication in an additional 12,649 individuals from the same ethnic groups. We identified five susceptibility loci. Four were at previously reported loci on 17q21, near IL1RL1, TSLP and IL33, but we report for the first time, to our knowledge, that these loci are associated with asthma risk in three ethnic groups. In addition, we identified a new asthma susceptibility locus at PYHIN1, with the association being specific to individuals of African descent (P = 3.9 × 10 −9 ). These results suggest that some asthma susceptibility loci are robust to differences in ancestry when sufficiently large samples sizes are investigated, and that ancestry-specific associations also contribute to the complex genetic architecture of asthma.
Asthma is a common, complex disease that affects over 300 million people worldwide 1 . In the United States, the prevalence of asthma from [2001] [2002] [2003] varied between ethnic groups, ranging from 7.7% in European Americans to 12.5% in African Americans and 3.9-14.5% in Latino Americans 2 . Estimates of heritability indicate that 35-80% of the variation in risk of asthma is attributable to genetic variation 3, 4 , yet attempts to identify asthma susceptibility alleles by candidate gene and positional cloning studies had relatively few successes 5, 6 . Most genome-wide association studies (GWAS) of asthma were conducted in relatively small samples of Europeans 7 , European Americans [8] [9] [10] , Mexicans 11 , Puerto Ricans 12 and African Americans and African Caribbeans 13 and did not identify significant associations or associations that replicated across studies. In contrast, the association at the IKZF3-ZPBP2-GSDMB-ORMDL3 locus on chromosome 17q21 (henceforth referred to as the 17q21 locus) has been consistently replicated as an asthma susceptibility locus in ethnically diverse subjects from Europe, North America and Asia [14] [15] [16] [17] [18] [19] [20] [21] [22] . Recently, a large meta-analysis of GWAS in European populations, called the Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations l e t t e r s GABRIEL Study 23 , reported significant associations with SNPs at six loci, including the 17q21 locus and five other regions not identified in previous GWAS of asthma. However, it is currently unknown whether the additional associations, implicating HLA-DQ, IL1RL1-IL18R1, IL33, SMAD3 and IL2RB1, play an important role in asthma risk in European populations only or whether the earlier studies were underpowered to detect associations with these loci.
The combined results of the previous GWAS for asthma highlight the challenges in the search for genetic risk factors for asthma. These include the large number of statistical tests performed (with millions of polymorphisms), missing genotype information (especially for rare variants and because of inadequately designed genotyping platforms for non-European populations), modest effect sizes for associated alleles, heterogeneity in the clinical definition of disease and the effects of a large number of potentially important environmental exposures; all of these factors reduce the power to detect associations. The simplest solution for increasing power is to pool data from many studies in a meta-analysis of genome-wide datasets for asthma, as in the GABRIEL Study in Europeans 23 . The goal of the EVE Consortium, which includes GWAS datasets from nine research groups in the United States (Table 1) , is not only to increase the power to identify SNPs, genes and pathways associated with asthma risk by combining studies but also to provide a better understanding of the patterns of variation in asthma risk genes or variants in the three major ethnic groups in the United States and to provide a more comprehensive understanding of the differences in genetic risk patterns between European-American, African-American and African-Caribbean, and Latino individuals. Only studies of diverse populations will allow for the discovery of both robust associations that replicate across ethnic groups and unique associations that contribute to the heterogeneity in disease prevalence across different ethnic groups. Moreover, studying populations with diverse ancestries can increase the resolution of associated regions as a result of different patterns of linkage disequilibrium (LD) between ethnic groups. The results reported here are based on analyses of >2 million SNPs in 3,246 cases with asthma, 3,385 non-asthmatic controls, 1,702 asthma case-parent trios, and 355 family based cases and 468 family-based controls, comprising three ethnic groups: European American, African American and African Caribbean, and Latino ( Table 1) .
We performed four genome-wide investigations: one meta-analysis in each of three ethnic groups and one in the combined sample. The quantile-quantile plots of the results (Supplementary Figs. 1-4 ) indicate that none of the studies showed inflation in their test statistics but also revealed an abundance of small P values, especially in the combined sample. In each of the four meta-analyses, we expected (on average) approximately two P values to be smaller than 10 −6 by chance alone. We observed 34 SNPs with P < 10 −6 in the European-American subjects, 4 such SNPs in the African-American and African-Caribbean subjects, 32 in the Latino subjects and 75 in the combined meta-analyses (Supplementary Fig. 5 ). In the European Americans, 33 of these SNPs are at the 17q21 asthma locus; one additional SNP on chromosome 17 (rs9891949) is 27 Mb from the 17q21 locus. In the African Americans and African Caribbeans, two of the SNPs are in PYHIN1 on chromosome 1q23 and two are in the intergenic region between the NNMT and C11orf71 loci on chromosome 11q23. In the Latinos, 13 of the SNPs are on chromosome 3q27 around RTP2, 1 is on chromosome 5q33 in GALNT10, 12 are at the chromosome 17q21 locus and 2 are on chromosome 19q12 between the CCNE1 and C19orf2 loci. One SNP in an intron of RTP2, rs2017908, reached genome-wide significance in the Latino samples (P = 4.4 × 10 −9 ). The 75 SNPs with P < 10 −6 in the combined meta-analysis occur in 15 chromosomal regions; the most significant SNP in each region with at least one P < 10 −6 in the combined sample or in one of the ethnic groups is shown in Table 2 , with the risk allele frequencies shown in Supplementary Table 1. Among these 75 SNPs, those at the 17q21, IL1RLI and TSLP loci reached genomewide significance in the combined sample (defined as P < 2 × 10 −8 ) (Supplementary Figs. 6-8) . The results for all SNPs with P < 10 −6 are listed in Supplementary Tables 2 and 3 .
We selected one SNP from each of the 15 regions with at least one P < 10 −6 for replication studies (as described in Table 2 ). The samples used for replication are described in the Supplementary Note and Supplementary Table 4 , and the results of those studies are shown l e t t e r s in Table 3 . Two SNPs (rs4653433 near SRP9 on chromosome 1q and rs9891949 near AURK on chromosome 17p) could not be assayed in the replication samples. Using a Bonferroni-corrected (for 13 tests) P < 0.0038 as the threshold for significance in the replication studies, SNPs in five regions were significantly associated with asthma in the replication samples (Table 3) . SNPs near the 17q21 locus and IL1RL1, TSLP and IL33 were associated with asthma in all three ethnic groups in the replication studies, whereas the PYHIN1 association was specific to the African-American replication samples. Notably, the associated SNPs in PYHIN1 occur with minor allele frequencies of 0.26-0.29 in the African-American and African-Caribbean controls, but they are not polymorphic in European Americans and occur at low frequencies (<0.05) in the Latino populations. However, multiple other SNPs in the PYHIN1 region showed evidence for association only in the African-American and African-Caribbean sample (Fig. 1) , whereas none of the SNPs showed evidence of association with asthma in Latinos or European Americans ( Supplementary  Fig. 9 ), suggesting that this association may be specific to populations of African descent. In fact, rs1102000 in PYHIN1 (also known as IFIX) has a relatively large effect size (odds ratio = 1.34 in the GWAS metaanalysis and odds ratio = 1.23 in the replication samples), suggesting an important role for this gene in risk for asthma in African-American and African-Caribbean populations.
The associations with SNPs in PYHIN1 (encoding pyrin and HIN domain family member 1; also known as IFIX, encoding interferon inducible nuclear protein X) with asthma are the first genome-wide significant associations reported in African Americans or African Caribbeans and may be the first asthma susceptibility gene identified Chr., chromosome; # SNPs, number of SNPs in a 1-Mb region with P < 1 × 10 -6 ; NA, not available (the SNP was not polymorphic).
a Genome-wide significant in the combined sample. b Genome-wide significant in Latinos only. The most significant SNP in each region with at least one P < 1 × 10 -6 in the combined sample or in at least one ancestry group, sorted by chromosome. Results for all SNPs with P < 1 × 10 -6 are shown in supplementary table 2 (P values) and supplementary table 3 (minor allele frequencies and imputation quality scores).
l e t t e r s that is specific to populations of African descent. The associated SNPs are in an LD bin in the HapMap YRI samples spanning ~30 kb within the seventh intron of the gene, suggesting that the causal variation is contained within this intron. Imputation of additional SNPs in PYHIN1 using pilot data from the 1000 Genomes Project yielded no additional signals of association (Supplementary Fig. 10 ). However, the incomplete coverage of PYHIN1 makes any conclusions regarding causal variation inaccurate (Supplementary Fig. 11) . Notably, the most strongly associated variants discovered in this study are not present in populations of European descent. Although, it is possible that rare variants in PHYIN1 that are not tagged by the SNPs included in this study are risk alleles for asthma in European-American and Latino populations, none of the multiple SNPs in this gene that were associated with asthma in the African-American and African-Caribbean populations showed evidence for association in the European Americans or Latinos. This further suggests that the African-specific variants may be causal or in LD with other African-specific causal variants in this gene. Moreover, estimates of local ancestry at PYHIN1 in the African-American and African-Caribbean samples did not differ between cases and controls for any of the studies (combined P = 0.77; see Supplementary Table 6 for more details), indicating that the African-American-specific association is present in the absence of an admixture signal and that the observed association is not caused by uncorrected local ancestry. At present, little is known about the function of PYHIN1, although it is expressed in both adult leukocytes and lung tissues, and the pyrin domain is a protein-protein interaction domain that is present in many interferon-inducible proteins that functions in both apoptotic and inflammatory pathways (see URLs). This family of genes has been previously associated with autoimmunity 24 , but to date, PYHIN1 has not been implicated in asthma pathogenesis. Lastly, we examined the evidence for association with SNPs that were associated with asthma in previous GWAS other than those included in the EVE Consortium meta-analysis (Supplementary Table 5 ). These included SNPs in or near HLA-DQ (refs. 9,23) , the 17q12 asthma locus 23 We were able to replicate at P < 0.05 associations with SNPs at the HLA-DQ locus in all three ethnic groups and in the combined sample, although no single SNP was associated in all three groups. The two SNPs associated at the 17q21 asthma locus in the GABRIEL Study were also associated with asthma in our study, although one (rs2894194) showed little evidence for association in the African-American and AfricanCaribbean samples. Among the remaining SNPs associated in the GABRIEL Study, we replicated associations with the same SNPs in or near IL18RL1, IL33, SLC22A5, SMAD3 and RORA. SNPs at the latter three loci were associated only in the European-American sample. Lastly, we replicated associations with two SNPs in RAD50, with the signals coming largely from the Latino and African-American and African-Caribbean samples. A SNP at the IL2RB locus that was associated with asthma in the GABRIEL Study was almost significant in the European-American EVE Consortium sample (P = 0.06). We did not replicate associations with SNPs at the IL13 (refs. 9,23) and
The results reported here highlight the importance of studying large datasets of diverse populations in several ways. First, the large sample size allowed us to first discover and then replicate loci with modest effects. For example, SNPs at the IL1RL1, TSLP and IL33 loci did not reach genome-wide significance in any of the ethnic-specific metaanalyses, but SNPs in IL1RL1 and TSLP reached this threshold of significance and SNPs in IL33 approached genome-wide significance in the overall analysis ( Table 2 and Supplementary Figs. 7,8 and 12) . The modest, but real, effect of variants on asthma risk likely explains why this locus was not identified as an asthma susceptibility locus in previous GWAS in individual samples [7] [8] [9] [10] [11] 13 but was among the most significant associations in the EVE Consortium and GABRIEL Study meta-analyses.
Second, the diverse ancestries of the EVE Consortium samples provided a more accurate and more complete picture of asthma risk by identifying common variants at four loci (the 17q21 locus, and IL1RL1, TSLP and IL33 loci) that increase risk in all ethnic groups and at least one locus (at PYHIN1) that may contribute to risk only in populations of African descent. Replication of previously associated variants in the EVE Consortium samples may also provide additional insights into those genes. For example, the SNPs in or near SMAD3 and RORA reported in the GABRIEL Study meta-analysis were modestly associated with asthma in the European-American EVE Consortium samples but showed no association in the African-American and African-Caribbean samples, suggesting that these may be risk variants only in populations of European descent. We anticipate that ongoing studies in the EVE Consortium datasets will identify other loci contributing to asthma risk and ultimately provide a better understanding of the molecular pathways and networks that are common to the risk architecture of asthma in diverse populations and those that are specific to certain groups.
URL. PYHIN1 search on AceView, http://www.ncbi.nlm.nih.gov/ IEB/Research/Acembly/av.cgi?exdb=AceView&db=36a&term=ifix &submit=Go.
METhods
Methods and any associated references are available in the online version of the paper at http://www.nature.com/naturegenetics/.
Note: Supplementary information is available on the Nature Genetics website. Figure 1 Results of the meta-analysis on the chromosome 1 region of association in African Americans and African Caribbeans. The relative location of PYHIN1 and the direction of transcription are shown in the lower portion of the figure, and the chromosomal position is shown on the x axis. The light blue line shows the recombination rate across the region (right y axis), and the left y axis shows the significance of the associations. The large red diamond shows the P value for rs1102000. The small diamonds show the P values for all other SNPs and are color coded according to the level of LD with rs1102000 in the HapMap YRI population (red, r 2 > 0.9; orange, r 2 = 0.7-0.9; yellow, r 2 = 0.5-0.7). Results for the European-American, Latino and combined meta-analysis are shown in supplementary Figure 9 .
